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ABSTRACT: Herein we present a supramolecular (delayed luminescent) Eu(III)-based pH-responsive probe/sensor with the ability 
to detect the urease-mediated hydrolysis of urea in aqueous solution. A series of photophysical titrations show this Eu(III) chelate 
behaves as an ‘on-off’ luminescent switching probe, with its luminescence being quenched upon urea being enzymatically convert-
ed into ammonia and carbon dioxide. Calculation of the rate constant (k) and activation energy (Ea) for this hydrolysis reaction are 
detailed; the results demonstrate a direct observation of enzymatic activity in solution by the sensor. The potential application of 
this probe in detecting the onset of catheter-associated urinary tract infections (CAUTIs) is also demonstrated by incorporating 
1.Eu into water-permeable hydrogels that can be utilized as an alternative coating for catheters. 
INTRODUCTION 
Catheter-associated urinary tract infection (CAUTI) is one 
of the most common health-care associated infections 
worldwide, accounting for up to 40% of all nosocomial 
infections.1,2 Approximately 20% of all hospitalized pa-
tients are catheterized.2 Currently, the most commonly 
deployed prosthetic medical device is the Foley indwell-
ing urethral catheter.1d,2b The development of CAUTIs has 
been directly linked to the duration of catheterization; 
nearly 100% of patients undergoing long-term catheteri-
zation (≥ 28 days) are found to develop catheter-
associated bacteriuria (CAB).1a-c While most cases of CAB 
are asymptomatic and do not require treatment, some 
individuals can experience symptomatic episodes of 
CAUTI, which can result in pyelonephritis, septicaemic or 
endotoxic shock, and ultimately death.1c,2b These episodes 
are triggered by the occurrence of catheter encrustation, 
where the formation of crystalline polymicrobial-based 
biofilms on the inner and outer surface of the catheter 
tube causes the device to become blocked, and as such 
obstructs urinary flow.3 The bacterial species most associ-
ated with catheter encrustation and CAUTI are urease-
producing microorganisms; specifically Proteus mirabilis, 
Proteus vulgaris, and Providencia rettgeri.1,2 Their ability 
to secrete urease, an enzyme that catalyzes the hydrolysis 
of urea (one of the primary constituents within urine) 
into ammonia and carbon dioxide, results in the pH of the 
urine being increased towards alkaline, which induces the 
precipitation of calcium and magnesium phosphate crys-
tals from the urine.4 These crystals accumulate within the 
bacterial layers of the biofilm, making it highly crystalline 
with increased resistance to both the hosts immune sys-
tem and to antibiotic treatment.3a,5 Several strategies have 
been employed to prevent the onset of CAUTI, the major-
ity of which involve coating or impregnating the catheter 
material (hydrogels and other related soft materials) with 
antimicrobial agents that will counteract bacterial adhe-
sion.1c,2a These agents include silver alloys,6 antibacterials,7 
liposomes,8 and urease inhibitors.9 Nevertheless, no single 
prosthetic medical device currently exists that is able to 
completely inhibit CAB from developing during catheteri-
zation. Consequently, focus has turned to finding ways in 
which CAUTI can be quickly diagnosed in order to permit 
early treatment. The primary diagnostic tool currently 
utilized in the clinic to monitor CAB is the bromothymol 
Scheme 1. Structural formula of the cationic complex 1.Eu 
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blue colorimetric sensor developed by Stickler, which 
changes from a yellow (pH 6) to blue (pH 8) color in re-
sponse to the pH of the urine being elevated by the pres-
ence of Proteus bacteria.10 Herein we describe an alterna-
tive route for diagnosing the onset of CAUTI through the 
use of a lanthanide-based (Ln(III)) pH-responsive lumi-
nescent probe (1.Eu, Scheme 1), which in combination 
with the enzyme urease, can monitor the hydrolysis of 
urea (either in solution or within a biocompatible materi-
al) in real time. 
As we and others have demonstrated, lanthanide lumi-
nescence is a powerful analytical tool that can be exploit-
ed for sensing and imaging biological systems.11 In par-
ticular, we have shown that such luminescent probes can 
be employed for observing enzymatic reactions in solu-
tion in real-time.12 This includes the development of gly-
cosylated Ln(III)-based cyclen complexes for monitoring 
glycosidase enzyme activity and Tb(III)-based cyclen ma-
leimide complexes for monitoring glutathione reduc-
tase.12a,b In addition, we have also designed several Ln(III)-
based pH-responsive luminescent sensors,13 some of 
which were developed to mimic logic gate operations14a,b, 
while others were conjugated to gold nanoparticles.14c,d         
One example of such a pH responsive design is the Eu(III) 
cyclen complex 1.Eu; a highly water soluble coordinative-
ly unsaturated octadentate (cationic) complex possessing 
a single axial metal bound water molecule. This system 
functions as a reversible luminescent ‘off-on-off’ sensor 
within the pH range of 2 – 10. The pH-dependent nature 
of this triacetamide-substituted cyclen derivative arises 
from the covalently attached 1,10-phenanthroline (phen), 
which functions as an antenna for populating the 5D4 ex-
cited state of Eu(III).15 Specifically, we have demonstrated 
that the phosphorescent emission of 1.Eu has a bell-
shaped pH dependency; corresponding to the pH values 
of 2 – 4, 5 – 7, and 8 – 10.15c We therefore anticipated that 
1.Eu could potentially be utilized as a spectroscopic ‘on-
off’ sensor/probe to detect the presence of urease-
secreting bacteria within urinary catheters. This could be 
achieved by impregnating water-permeable hydrogels, 
that could be used as an alternative coating material, with 
the complex 1.Eu.16 Through photophysical analysis, we 
demonstrated that this was indeed possible; the urease-
mediated hydrolysis of urea results in the pH of the sys-
tem being elevated and as such causes the metal-centered 
emission of 1.Eu to be quenched. Moreover, we show that 
the rate of this quenching increases at elevated tempera-
ture and upon increasing the quantity of enzyme units 
(U).  
RESULTS 
Synthesis and characterization 
Both the synthesis and characterization of ligand 1 and its 
corresponding Eu(III) complex 1.Eu have been previously 
reported by us.15a The hydration state (q) was determined 
by measuring the excited state lifetimes of 1.Eu in H2O 
and D2O, with the number of metal bound water mole-
cules in solution being confirmed as one (see Supporting 
Information, Figure S1).15a  
Luminescent stability of 1.Eu in solution 
Population of the Eu(III) excited state was achieved by 
indirect excitation of the phen antenna, which was con-
firmed upon recording the time-delayed emission and 
excitation spectra of 1.Eu.  
The luminescence response of 1.Eu (1 × 10−5 M), in the ab-
sence and presence of either urea or urease, was moni-
tored in H2O over 24 h. Since the normal concentration 
range of urea in human blood plasma is between 3.0 – 6.5 
× 10−3 M and urease behaves as a catalyst, concentrations 
of 2.3 × 10−3 M and 0.01 – 0.1 U were utilized, respectively. 
As expected, five distinct phosphorescence transitions 
were observed at 580, 593, 615, 654, 683, and 701 nm upon 
indirect excitation of 1.Eu at 266 nm, which can be as-
signed to the 5D0→7FJ (J = 0 – 4) transitions of Eu(III), as 
shown in Figure 1. Indeed, the intensity of all five emission 
bands was seen to remain constant in aqueous solution at 
22 °C, indicating 1.Eu was stable towards Eu(III) dissocia-
tion. Similarly, no changes in the luminescent properties 
of 1.Eu were exhibited when in the presence of urea (2.3 × 
10−3 M) or urease (0.1 U), with the metal-centered emis-
sion remaining ‘switched on’ for up to 24 h (see Support-
ing Information, Figure S2 – 3). Importantly, repeating 
these measurements at 37 °C further showed that the lu-
minescent properties of 1.Eu were not temperature de-
pendent. Regardless of urea or urease being present, no 
Figure 1. a) The phosphorescence spectrum of 1.Eu (1 × 10−5 M) 
over multiple time points, recorded in H2O at 295 K (λexc = 266 
nm). b) Changes in the Eu(III) emission as a function of time. 
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variation was seen in the emission intensity (see Support-
ing Information, Figure S4 – 5). These results therefore 
indicate that the Eu(III) emission is not dependent on the 
local environment of the pH sensor, which is important to 
establish with respect to incorporating the sensor into soft 
polymeric materials (e.g. hydrogels).  
Detecting the urease-mediated hydrolysis of urea pho-
tophysically 
With the luminescent behavior of 1.Eu investigated inde-
pendently with both urea and urease, we next determined 
whether 1.Eu could be utilized as a pH-responsive probe 
to monitor the urease-mediated hydrolysis of urea. This 
was achieved by recording the photophysical properties of 
1.Eu before and 60 min after the addition of urease (0.01 – 
0.10 U; increments of 0.01 U) at 22 °C. 
The ground state properties were firstly investigated; the 
UV-vis absorption spectra of 1.Eu was characteristic of 
substituted phen derivatives, consisting of two main 
bands centered at 230 and 266 nm, which are assigned to 
the π-π* intra-ligand transitions of the antenna moiety.15 
The addition of urease (0.01 U) to a solution of 1.Eu and 
urea resulted in the urea being rapidly hydrolyzed. This 
caused a marked bathochromic shift in the lower energy 
absorption band of the phen antenna (266→274 nm) and 
the concomitant appearance of a small shoulder at ca. 312 
nm, as shown in Figure 2a, with the appearance of several 
isosbestic points. This red shift corresponds with the 
changes exhibited in the pH titration previously reported 
by Leonard and co-workers, where upon increasing the 
pH from 5.5→9.5 the λmax of the 266 nm band was seen to 
red shift by ca. 8 nm.15a Moreover, this bathochromic shift 
was evident regardless of the units of urease added 
(0.01→0.10 U) to the solution of 1.Eu and urea (see Sup-
porting Information, Figure S6a). 
Both the delayed lanthanide luminescence and the fluo-
rescence spectra were obtained by exciting the same solu-
tion at 266 nm. As anticipated, the Eu(III) emission was 
‘switched off’ upon the addition of 0.01 U of urease, with 
ca. 90% quenching being observed after 60 min, as 
demonstrated in Figure 2b; this being the direct result of 
the local pH environment of 1.Eu changing. Increasing 
the concentration of urease (0.01→ 0.10 U; 0.01 incre-
ments) added to 1.Eu resulted in the same amount of 
quenching in the Eu(III)-centered emission being exhibit-
ed (see Supporting Information, Figure S6b). However, 
the rate at which the emission was ‘switched off’ in-
creased.  
The changes observed in the fluorescence emission spec-
tra of 1.Eu were much less dramatic; the intensity of the 
ligand fluorescence was reduced by ca. 40% and a red-
shift in the λmax from 400 to 415 nm was observed follow-
ing the addition of 0.01 U of the enzyme, as shown in Fig-
ure 2c. As before, no difference in the extent of quenching 
was seen upon increasing the quantity of units of urease 
added to 1.Eu (see Supporting Information, Figure S6c). 
Excitation spectra were also recorded before and after the 
addition of enzyme; all the spectra structurally matched 
those of the absorption spectra (see Supporting Infor-
mation, Figure S7), and showed that the sensitization 
process from the antenna to the Ln(III) center was indeed 
modulated by the addition of enzyme and the resultant 
change in pH. These results clearly demonstrate that 1.Eu 
can be used to observe the enzymatic catalyzed hydrolysis 
of urea in real time, even at micromolar concentrations.   
Determination of the rate constant (k) 
In order to quantify the enzymatic activity of urease in 
hydrolyzing the urea in solution into ammonia and car-
bon dioxide, the rate constant (k) of this reaction was 
next calculated by plotting the quenching in the Eu(III)-
centered emission of 1.Eu as a function of time for all the 
5D0→7FJ (J = 0 – 4) transitions.  
The resulting titration profiles are given in Figure 3 and 
clearly show that the addition of a higher quantity of ure-
ase units results in the Eu(III) emission being quenched at 
a faster rate (see Supporting Information, Figure S8, for 
other transition bands). In general, all the Eu(III)-
centered emission bands were quenched to the same ex-
tent (up to 90%) ca. 60, 20, and 15 min after the addition 
of 0.01 – 0.02, 0.03 – 0.04, and 0.05 – 0.10 U of urease, re-
spectively. Fitting this luminescent quenching to a mono-
exponential function allowed for the rate constant value 
to be determined for each of the 5D0→7FJ transitions with-
in the enzymatic unit range of 0.01 – 0.1 U. As shown in 
Figure 4, the rate constant was seen to linearly increase as 
a function of urease activity, with the lowest and highest 
k values being given for 0.01 and 0.10 U of urease, respec-
tively. This first-order relationship, where the rate of reac-
tion was seen to be directly proportional to the concen-
tration of urease, demonstrated that the higher the quan-
tity of urease units added to the urea and 1.Eu solution, 
 
Figure 2. a) The UV-vis absorption, b) the phosphorescence, and c) the total emission spectrum of 1.Eu before and 60 min after the addi-
tion of 0.01 U of urease, measured in an aqueous solution of urea (2.3 × 10−3 M) at 295 K.  
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the greater the decrease exhibited in the activation energy 
of the reaction, and the faster the rate of hydrolysis.  
The effect of temperature on the rate of hydrolysis was 
also studied by repeating the above measurements at 
both 30 and 37 °C (see Supporting Information, Figure S9 
– 10). At elevated temperatures the Eu(III)-centered emis-
sion became ‘switched off’ much more rapidly. More than 
90% quenching in the phosphorescence of 1.Eu occurred 
45, 20, 10, and 5 min after the addition of 0.01, 0.02, 0.03 – 
0.05, and 0.06 – 0.08 U of urease, respectively, when at 37 
°C (see Supporting Information, Figure S10). Indeed, in-
creasing either the temperature or the quantity of enzyme 
units added to the solution of 1.Eu and urea gave rise to a 
higher rate constant, whereby k37°C > k30°C > k22°C and k0.1U 
> k0.01U of enzyme (see Supporting Information, Figure 
S11). This can be explained by the fact that the enzymatic 
activity of urease increases as a function of temperature, 
with the optimal temperature of urease being known to 
be 60 °C.17 As such, the conversion of urea into ammonia 
and carbon dioxide occurs at a quicker rate at higher 
temperatures, and in turn causes the pH of the system to 
also change at a much faster rate,18 which is observed by 
the Eu(III) probe. Hence, 1.Eu in combination with urea, 
can be employed in a luminescent assay to monitor en-
zymatic hydrolysis reactions in real time in solution. 
Determination of the activation energy (Ea) from the 
Arrhenius Equation 
Having established a relationship between the rate of hy-
drolysis of urea and temperature, the activation energy 
(Ea) of this reaction was next calculated by utilizing the 
Arrhenius equation [ln(k) = ln(A) − Ea/RT].19 Plotting the 
rate constant as a function of 1/T for all the 5D0→7FJ (J = 0 
– 4) transitions resulted in a negative linear correlation 
being evidenced in all four of the Arrhenius plots, with 
ln(k) decreasing as the quantity of urease was increased 
by 0.01 U intervals between 0.02 – 0.05 U (see Supporting 
Information, Figure S12). The average values obtained for 
Ea (activation energy) and A (pre-exponential factor) are 
presented in Table 1 for each enzymatic unit. Indeed, both 
the mean Ea and A for the urease-mediated hydrolysis 
 
Figure 3. Changes in the delayed-Eu(III) emission of 1.Eu (1 × 10−5 M) as a function of time in an aqueous solution of urea (2.3 × 10−3 
M) at 295 K (λexc = 266 nm), measured at a) 580 nm, b) 593 nm, c) 615 nm, and d) 701 nm upon the addition of urease (0.01 – 0.10 U). 
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Figure 4. Changes in the rate of hydrolysis of urea as a function 
of urease units at 295 K, calculated from the quenching in Eu(III)-
emission of 1.Eu (shown in Figure 3), with all linear fits obtained 
having a R2 ≥ 0.98. 
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reaction of urea were found to correlate well with report-
ed literature, with an average value of 44.9 kJmol−1 and 1.4 
× 107 min−1 being calculated for each, respectively.20 This 
relatively low value for the Ea indicates that the hydrolysis 
of urea proceeds at a rapid rate in solution. This means 
the pH of the solution changes at a fast rate and as such 
explains the dramatic quenching exhibited for 1.Eu. 
IC50 toxicity studies of 1.Eu and urea 
With the intention of incorporating this Eu(III)-based 
pH-responsive probe into biomaterials that are currently 
utilized for catheters and the attached urinary collection 
bags, we next investigated the cytotoxicity properties of 
1.Eu in vitro. Both the complex 1.Eu and urea were found 
to be relatively low in toxicity and potency, with an IC50 
value of 200 μM and 10 mM being given for each, respec-
tively (see Supporting Information, Figure S13). These 
high IC50 values suggest that prosthetic medical devices, 
such as catheters, impregnated with 1.Eu would not be 
expected to have any major negative impact on a patients’ 
health or body.  
Water-permeable hydrogels impregnated with 1.Eu 
Having studied the photophysical properties of 1.Eu in 
solution, we next turned our attention towards forming 
soft luminescent biomaterials; the intention being that 
they could be utilized as diagnostic materials to detect 
the onset of CAUTIs.  
With this in mind, the complex 1.Eu was non-covalently 
impregnated within water-permeable hydrogels using a 
poly(HEMA) matrix, which was prepared according to our 
previously published methodology.14a,16 A homogenous 
solution of HEMA, EGDMA, and 1.Eu were polymerized 
under free-radical polymerization using AIBN to afford a 
hard brittle acrylic monolith with the complex encapsu-
lated (0.033% w/w). The monolith was then swelled in 
deionized water to yield soft polymer hydrogel materials 
of 1.Eu, which were transparent to the naked eye under 
ambient light and red emissive upon irradiation at 254 
nm, as is evident from Figure 5.  
As anticipated, the characteristic spectroscopic properties 
of complex 1.Eu were retained upon encapsulation within 
the hydrogel. The Eu(III)-centered emission spectra, 
which was obtained by suspending the swelled gel (30 
mm × 10 mm × 1.2 mm) in a stirred solution of Millipore 
H2O, matched exactly with that observed for 1.Eu in solu-
tion (Figure 6; c.f 1.Eu (Hydrogel)); this suggests that the 
coordination environment of the Eu(III) ion was not sub-
stantially changed by the polymeric matrix. Furthermore, 
Table 1. Summary of the activation energy and pre-
exponential factor for the urease-mediated hydrolysis of urea 
in aqueous solution, determined from the quenching in Eu(III) 
emission of 1.Eu. 
Urease / U Ea / kJmol−1 A / min−1 
0.02 46.7 ± 2.3 3.2 × 107 ± 140 
0.03 42.9 ± 2.8 5.2 × 106 ± 190 
0.04 43.1 ± 2.9 4.5 × 106 ± 180 
0.05 46.8 ± 3.4 1.3 × 107 ± 220 
 
 
Figure 5. Photographs of the hydrogels encapsulated with 1.Eu 
and swelled in deionized H2O. Images were captured a) under 
ambient light and b) upon irradiation at 254 nm. 
 
Figure 6. The a) UV-vis absorption, b) phosphorescence, and c) 
excitation spectra of the swelled 1.Eu-based hydrogel, before 
and 200 min after the addition of 0.5 U of urease, measured in an 
aqueous solution of urea (2.3 × 10−3 M) at 295 K. 
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the UV-vis absorption and excitation spectra of these hy-
drogels also correlated with the results obtained in solu-
tion, with the main π-π* band at 266 nm being clearly 
exhibited in both cases (Figure 6; c.f 1.Eu (Hydrogel)). 
To ascertain whether these luminescent hydrogels were 
also pH-responsive, their ability to monitor the hydrolysis 
of urea into carbamic acid and sense the associated 
change in pH from acidic to basic, was studied. As with 
the solution studies, the photophysical parameters of the 
gel were recorded both before and 200 min after the addi-
tion of urease (0.5 U) at 22 °C, using urea as the superna-
tant. Both the UV-vis absorption and luminescence spec-
tra coincided with that observed in solution for 1.Eu, as 
shown in Figure 6; the π-π* band in the UV-vis was once 
again red shifted by ca. 10 nm, while the Eu(III)-centered 
emission was quenched by over 85%. This ‘on-off’ re-
sponse was also visible to the naked eye under UV light, 
where by the gel was seen to change from being predomi-
nantly bright red (on) to a faint pink/purple (off) color 
upon hydrolysis of the urea in solution, which is evident 
from Figure 7. Repetition of these measurements using a 
higher concentration of enzyme (1.0 U) and an elevated 
temperature (37°C) resulted in exactly the same spectro-
scopic trends being evidenced (see Supporting Infor-
mation, Figure S14 – 19). However, the rate at which the 
Eu(III) emission was ‘switched off’ varied. Increasing both 
the enzyme (0.5 → 1.0 U)  and the substrate concentra-
tion (2.3 × 10–3 → 10 × 10–3 M of urea) gave rise to a faster 
rate of hydrolysis, and consequently increased the rate of 
luminescent decay exhibited for the hydrogel by 1.5 fold 
(see Figure 8). Furthermore, raising the temperature of 
the system to physiological temperature (37 °C) also 
caused the rate of quenching to substantially increase, 
with the ‘on-off’ response being observed in less than 60 
min (see Supporting Information, Figure S20). Unlike the 
solution studies, which are instantaneous, the response 
time of the hydrogels are diffusion controlled.14a,16 As 
such, diffusion of the substrate and enzyme into the hy-
drogel matrix depends on the ambient conditions, as well 
as both the gels thickness (diffusion length) and surface 
area (accessible pores). While this response time is slower 
than that exhibited in solution, it is still relatively fast, 
which signifies the potential of this design for clinical use.  
To ensure that these hydrogels were robust and that the 
complex did not leech out of the polymeric matrix, we 
also recorded the emission spectra of the supernatant 
solution over a 2 week period. Only a negligible amount 
of leeching of 1.Eu from the cross-linked matrix occurred 
at room temperature (see Supporting Information, Figure 
S21 – 22), indicating that the complex was indeed retained 
 
Figure 7. Photographs of the a) ‘on’ and b) ‘off’ state of the hy-
drogel, when irradiated at λmax = 254 nm. Left image was ac-
quired before the addition of urease and the right image 200 min 
after.  
 
Figure 8. Changes in the delayed-Eu(III) emission of the swelled 1.Eu-based hydrogel as a function of time in an aqueous solution of 
urea at 295 K (λexc = 266 nm), measured at 580 nm, 593 nm, 615 nm, 654 nm, 683 nm, and 701 nm upon the addition of urease. Concen-
trations of urea and urease utilized were a) 2.3 × 10–3 M, 0.5 U, b) 2.3 × 10–3 M, 1.0 U, c) 10 × 10–3 M, 0.5 U, and d) 10 × 10–3 M, 1.0 U. 
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within the hydrogel. However, under physiological condi-
tions (37 °C) the complex slowly leeched out into the su-
pernatant solution; a gradual, but minimal increase in the 
metal-centered emission of the supernatant was observed 
for 7 days, after which the intensity plateaued (see Sup-
porting Information, Figure S23 – 24).  
CONCLUSIONS 
In this article, we report on the development and applica-
tion of a pH-responsive luminescent probe that can be 
impregnated within soft polymer-based hydrogels to sig-
nal both biofilm formation and encrustation within cathe-
ters in the clinic. Specifically, we have demonstrated that 
this Eu(III)- based macrocyclic probe, 1.Eu, is capable of 
detecting the pH changes associated with the enzymatic 
hydrolysis of urea both in solution and when encapsulat-
ed within hydrogels. In particular, this system has been 
shown to behave in an ‘on-off’ responsive manner; as the 
urea is hydrolyzed to ammonia, the pH of the system 
changes from being mildly acidic to neutral/slightly alka-
line, and hence results in the luminescence of 1.Eu being 
quenched. Although the gel studies were only conducted 
as a means of providing proof of concept, the response 
time of the materials was relatively quick, especially un-
der physiological conditions. These preliminary results 
highlight the potential these materials have as diagnostic 
agents; a study that we are currently initiating.   
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